Summary

Cartilage Repair Market Growth & Trends

The global cartilage repair market size is expected to reach USD 8.08 billion by 2030, registering a CAGR of 4.5% from 2023 to 2030, according to a new report by Grand View Research, Inc.The market is expected to witness lucrative growth over the forecast period, owing to the increasing prevalence of bone & joint disorders, such as Osteoarthritis (OA), rising geriatric population, and surge in the number of accidents & related injuries across the globe.

An increasing number of road accidents worldwide are causing bone and joint injuries, which is anticipated to fuel the demand for cartilage repair products over the forecast period. For instance, as per data published by the World Health Organization (WHO) in November 2016, approximately 1.25 million people die each year in road accidents worldwide, owing to the influence of alcohol & reckless driving, use of mobile phone, and other associated factors such as bad weather conditions & improper road construction.

Around 30.0 million children and adolescents participate in youth sports in the U.S each year. This increase in sports activity increases incidents of injuries in athletes, which in turn propels the demand for cartilage repair products. According to research data by the American Orthopaedic Society for Sports Medicine, over 3.5 million athletes receive medical treatment due to sports injuries each year.

Cartilage Repair Market Report Highlights

• The cell-based modalities segment held the largest market share of over 60% in 2022 and is expected to grow at the fastest rate of 5.0% during the forecast period owing to rising preference for autologous chondrocyte transplantation for surgical treatment of damaged articular cartilage (chondral and osteochondral lesions)

• The hyaline cartilage segment held a significant market share in 2022 due to high susceptibility of damage to hyaline cartilage in case cartilage-related injuries and an increase in sport injuries

• North America is expected to dominate the share of over 45% in 2022, owing to the rising prevalence of bone & joint disorders, an increase in the number of accidents & injuries, and growing geriatric population in the region are expected to spur the cartilage regeneration market growth.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Modalities
1.1.2. Application
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. By Treatment modality
2.2.2. By Application
2.2.3. By Region
2.3. Competitive Insights
Chapter 3. Cartilage Repair Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Cartilage Repair Market Market Analysis Tools
3.4.1. Industry Analysis Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Cartilage Repair Market: Modality Estimates & Trend Analysis
4.1. Cartilage Repair Market: Key Takeaways
4.2. Cartilage Repair Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Cell Based
4.3.1. Cell based market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Non-Cell Based
4.4.1. Non-cell based market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Cartilage Repair Market: Application Estimates & Trend Analysis
5.1. Cartilage Repair Market: Key Takeaways
5.2. Cartilage Repair Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Hyaline Cartilage
5.3.1. Hyaline cartilage estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Fibrocartilage
5.4.1. Fibrocartilage market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Cartilage Repair Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Cartilage Repair Market: Key Takeaways
6.3. North America
6.3.1. Cartilage repair market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.6. Denmark
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.7. Sweden
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.8. Norway
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.7.2. Saudi Arabia
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Zimmer Biomet
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Stryker
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Collagen Solutions (US) LLC
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. BD (Becton, Dickinson and Company)
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. B. Braun SE
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Arthrex, Inc,
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Anika Therapeutics, Inc
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Smith + Nephew
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Vericel Corporation
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Johnson & Johnson Services, Inc
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Medcata International
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives